These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17540575)

  • 1. Analysis of crucial structural requirements of 2-substituted pyrimido[4,5-b][1,5]oxazocines as NK(1) receptor antagonist by axially chiral derivatives.
    Seto S; Asano J
    Bioorg Med Chem; 2007 Aug; 15(15):5083-9. PubMed ID: 17540575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK(1) antagonists.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1479-84. PubMed ID: 15713411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem; 2005 Oct; 13(20):5717-32. PubMed ID: 15993086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
    Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
    Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor.
    Mitra S; Banerjee TS; Hota SK; Bhattacharya D; Das S; Chattopadhyay P
    Eur J Med Chem; 2011 May; 46(5):1713-20. PubMed ID: 21392859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
    Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes.
    Swarna VM; Undem BJ; Korlipara VL
    Bioorg Med Chem Lett; 2007 Feb; 17(4):890-4. PubMed ID: 17169559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure-activity-relationships of aromatic substituted piperidine derivatives (author's transl)].
    Lambrecht G; Mutschler E
    Arch Pharm (Weinheim); 1975 Sep; ():676-87. PubMed ID: 1167082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structure-activity relationship studies of chalcones as SRS-A receptor antagonists].
    He KQ; Cheng GF; Xi FD; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1996; 31(11):878-80. PubMed ID: 9863261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
    Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
    Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
    Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.
    Mulè F; Amato A; Serio R
    Eur J Pharmacol; 2007 Sep; 570(1-3):196-202. PubMed ID: 17597603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological profile of non-peptide vasopressin antagonists.
    Galanski ME; Erker T; Studenik CR; Kamyar M; Rawnduzi P; Pabstova M; Lemmens-Gruber R
    Eur J Pharm Sci; 2005 Apr; 24(5):421-31. PubMed ID: 15784332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new structural motif for mu-opioid antagonists.
    Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
    J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.